Skip to main content
Erschienen in: Hernia 2/2022

25.05.2020 | Original Article

The use of a novel synthetic resorbable scaffold (TIGR Matrix®) in a clinical quality improvement (CQI) effort for abdominal wall reconstruction (AWR)

verfasst von: R. Lewis, B. Forman, M. Preston, E. Heidel, B. Alvoid-Preston, B. Ramshaw

Erschienen in: Hernia | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The use of hernia mesh is a common practice in abdominal wall reconstruction (AWR) operations. The high cost of biologic mesh has raised questions about the value of its use in AWR. Resorbable synthetic mesh may have the potential benefits of biologic mesh, minimizing the need for removal when infected, at a lower cost.

Methods

A hernia program has implemented the principles of clinical quality improvement (CQI) to improve patient outcomes. One process improvement attempt was implemented using a newly available resorbable synthetic scaffold. Long-term follow-up was obtained as a part of the CQI process.

Results

A total of 91 patients undergoing AWR were included between 8/11 and 9/15 (49 months). There were 58 female (64%) and 33 male (36%) patients. The average age was 57.2 years (28–80). The average BMI was 34.0 (17.6–53.4). There were 52 patients (57%) with recurrent hernias. Mean hernia defect size was 306.6 cm2 (24–720) and mean mesh size was 471.7 cm2 (112–600). Outcomes included a mean length of stay of 7.5 days (0–49), a recurrence rate of 12% (11/91) and a wound complication rate of 27% (25/91). The recurrence rate decreased to 4.5% (3/66) after several improvements, including adopting a transversus abdominus release (TAR) approach, were implemented. There were no mesh-related complications and no mesh removal (partial or total) was required. The mean follow-up length was 42.4 months (0–102).

Conclusion

In this group of patients, an attempt at process improvement was implemented using a resorbable synthetic scaffold for AWR. With no mesh-related complications and no mesh removals required, there was an improvement in value due to the decrease in mesh cost and improved outcomes over time. Long-term follow-up demonstrated the durability of the repair.
Literatur
1.
Zurück zum Zitat Poulose BK, Shelton J, Phillips S et al (2012) Epidemiology and cost of ventral hernia repair: making the case for hernia research. Hernia 16(2):179–183CrossRefPubMed Poulose BK, Shelton J, Phillips S et al (2012) Epidemiology and cost of ventral hernia repair: making the case for hernia research. Hernia 16(2):179–183CrossRefPubMed
2.
Zurück zum Zitat Holihan JL, Alawadi Z, Martindate RG et al (2015) Adverse events after ventral hernia repair: the visciouc cycle of complications. JACS 221(2):478–485 Holihan JL, Alawadi Z, Martindate RG et al (2015) Adverse events after ventral hernia repair: the visciouc cycle of complications. JACS 221(2):478–485
3.
Zurück zum Zitat Hjort H, Mathisen T, Alves A et al (2012) Three year results from a preclinical implementation study of a long-term resorbable surgcial mesh with time-dependent mechanical characteristics. Hernia 16:191–197CrossRefPubMed Hjort H, Mathisen T, Alves A et al (2012) Three year results from a preclinical implementation study of a long-term resorbable surgcial mesh with time-dependent mechanical characteristics. Hernia 16:191–197CrossRefPubMed
4.
Zurück zum Zitat Dorrance KA, Phillips AA (2018) Toward a national conversation on health: the transformative power of deregulated markets and market-driven innovation. Milit Med 183(Supp):239–243CrossRef Dorrance KA, Phillips AA (2018) Toward a national conversation on health: the transformative power of deregulated markets and market-driven innovation. Milit Med 183(Supp):239–243CrossRef
5.
Zurück zum Zitat Johnson PT, Alvin MD, Ziegelstein RC (2018) Transitioning to a high-value health care model: academic accountability. Acad Med 93(6):850–855CrossRefPubMed Johnson PT, Alvin MD, Ziegelstein RC (2018) Transitioning to a high-value health care model: academic accountability. Acad Med 93(6):850–855CrossRefPubMed
6.
Zurück zum Zitat Bittner R, Bingener-Casey J, Dietz U et al (2015) Guidelines for laparoscopic treatment of ventral and incisional abdominal wall hernias (International Endohernia Society (IEHS)-part 1). Surg Endosc 28:2–29CrossRef Bittner R, Bingener-Casey J, Dietz U et al (2015) Guidelines for laparoscopic treatment of ventral and incisional abdominal wall hernias (International Endohernia Society (IEHS)-part 1). Surg Endosc 28:2–29CrossRef
9.
Zurück zum Zitat Zimmerman B, Lindberg C, Plsek P (1998) Edgeware: insights from complexity science for health care leaders. VHA Inc, Texas Zimmerman B, Lindberg C, Plsek P (1998) Edgeware: insights from complexity science for health care leaders. VHA Inc, Texas
11.
Zurück zum Zitat Itani KMF, Rosen M, Vargo D et al (2012) Prospective study of single-stage repair of contaminated hernias using a biologic porcine tissue matrix: the RICH study. Surgery 152(3):498–505CrossRefPubMed Itani KMF, Rosen M, Vargo D et al (2012) Prospective study of single-stage repair of contaminated hernias using a biologic porcine tissue matrix: the RICH study. Surgery 152(3):498–505CrossRefPubMed
12.
Zurück zum Zitat Roth JS, Anthone GJ, Selzer DJ et al (2018) Prospective evaluation of poly-4-hydroxybutyrate mesh in CDC class 1/high-risk ventral and incisional hernia repair: 18 month follow-up. Surg Endosc 32(4):1929–1936CrossRefPubMed Roth JS, Anthone GJ, Selzer DJ et al (2018) Prospective evaluation of poly-4-hydroxybutyrate mesh in CDC class 1/high-risk ventral and incisional hernia repair: 18 month follow-up. Surg Endosc 32(4):1929–1936CrossRefPubMed
13.
Zurück zum Zitat Rosen MJ, BauerJJ HM et al (2017) Multicenter, prospective, longitudinal study of the recurrence, surgical site infection, and quality of life after contaminated ventral hernia repair using biosynthetic absorbable mesh: the COBRA study. Ann Surg 265(1):205–211CrossRefPubMed Rosen MJ, BauerJJ HM et al (2017) Multicenter, prospective, longitudinal study of the recurrence, surgical site infection, and quality of life after contaminated ventral hernia repair using biosynthetic absorbable mesh: the COBRA study. Ann Surg 265(1):205–211CrossRefPubMed
14.
Zurück zum Zitat Bittner JG, El-Hayek K, Strong AT et al (2018) First human use of hybrid synthetic/biologic mesh in ventral hernia repair: a multicenter trial. Surg Endosc 32:1123–1130CrossRefPubMed Bittner JG, El-Hayek K, Strong AT et al (2018) First human use of hybrid synthetic/biologic mesh in ventral hernia repair: a multicenter trial. Surg Endosc 32:1123–1130CrossRefPubMed
15.
Zurück zum Zitat Roth JS, Zachem A, Plymale MA, Davenport DL (2017) Complex ventral hernia repair with acellular dermal matrices: clinical and quality of life outcomes. Am Surg 83(2):141–147CrossRefPubMed Roth JS, Zachem A, Plymale MA, Davenport DL (2017) Complex ventral hernia repair with acellular dermal matrices: clinical and quality of life outcomes. Am Surg 83(2):141–147CrossRefPubMed
16.
Zurück zum Zitat Stephan B, Ramshaw B, Forman B (2015) Value-based clinical quality improvement (CQI) for patients undergoing abdominal wall reconstruction. Surg Technol Int 26:135–142PubMed Stephan B, Ramshaw B, Forman B (2015) Value-based clinical quality improvement (CQI) for patients undergoing abdominal wall reconstruction. Surg Technol Int 26:135–142PubMed
17.
Zurück zum Zitat Ramshaw B, Dean J, Forman B et al (2016) Can abdominal wall reconstruction be safely performed without drains? Am Surg 82(8):707–712CrossRefPubMed Ramshaw B, Dean J, Forman B et al (2016) Can abdominal wall reconstruction be safely performed without drains? Am Surg 82(8):707–712CrossRefPubMed
18.
Zurück zum Zitat Ramshaw B, Forman B, Moore K et al (2017) Real-world clinical quality improvement for complex abdominal wall reconstruction. Surg Technol Int 13(30):155–164 Ramshaw B, Forman B, Moore K et al (2017) Real-world clinical quality improvement for complex abdominal wall reconstruction. Surg Technol Int 13(30):155–164
Metadaten
Titel
The use of a novel synthetic resorbable scaffold (TIGR Matrix®) in a clinical quality improvement (CQI) effort for abdominal wall reconstruction (AWR)
verfasst von
R. Lewis
B. Forman
M. Preston
E. Heidel
B. Alvoid-Preston
B. Ramshaw
Publikationsdatum
25.05.2020
Verlag
Springer Paris
Erschienen in
Hernia / Ausgabe 2/2022
Print ISSN: 1265-4906
Elektronische ISSN: 1248-9204
DOI
https://doi.org/10.1007/s10029-020-02221-7

Weitere Artikel der Ausgabe 2/2022

Hernia 2/2022 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.